Drug information for 'CECLOR'

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL EQ 250MG BASE Discontinued   CEFACLOR Cefaclor LILLY 050521
2004-04-05 Label
2004-03-24 Letter
2003-03-10 Letter
1998-02-02 Review
CAPSULE; ORAL EQ 500MG BASE Discontinued   CEFACLOR Cefaclor LILLY   "
FOR SUSPENSION; ORAL EQ 125MG BASE/5ML Discontinued   CEFACLOR Cefaclor LILLY 050522
2004-04-05 Label
2004-03-24 Letter
2003-03-10 Letter
1998-02-02 Review
FOR SUSPENSION; ORAL EQ 250MG BASE/5ML Discontinued   CEFACLOR Cefaclor LILLY   "

Drug Adverse Effects information for 'CECLOR'

Role code Indications Reaction # Reports
PS NAIL INFECTION ALCOHOL WITHDRAWAL SYNDROME 2
PS NAIL INFECTION CHEST DISCOMFORT 2
PS NAIL INFECTION DIALYSIS 2
PS NAIL INFECTION DIZZINESS 2
PS NAIL INFECTION HAEMATOCRIT DECREASED 2
PS NAIL INFECTION HAEMOGLOBIN DECREASED 2
PS NAIL INFECTION HAEMOLYTIC URAEMIC SYNDROME 2
PS NAIL INFECTION HYPERHIDROSIS 2
PS NAIL INFECTION NAUSEA 2
PS NAIL INFECTION PLATELET COUNT DECREASED 1
PS NAIL INFECTION PYREXIA 2
PS NAIL INFECTION RENAL FAILURE ACUTE 2
PS NAIL INFECTION RESPIRATORY FAILURE 2
PS NAIL INFECTION SYNCOPE 2
PS NAIL INFECTION THROMBOTIC THROMBOCYTOPENIC PURPURA 2
PS NAIL INFECTION VOMITING 2
PS PHARYNGITIS HYPERSENSITIVITY 1
PS PHARYNGITIS VISUAL ACUITY REDUCED 1
SS SINUSITIS PHARYNGEAL OEDEMA 1
SS SINUSITIS PRURITUS 1
SS SINUSITIS URTICARIA 1